S
AMLX icon

SignatureFD’s Amylyx Pharmaceuticals AMLX Stock Holding History

SignatureFD’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Sell
93
-161
-63% -$2.49K ﹤0.01% 3168
2026
Q1 		$3.53K Buy
+254
New +$3.57K ﹤0.01% 2894

Other funds holding AMLX

MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PPWP
Premier Path Wealth Partners Madison, New Jersey $870M AUM 30% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SignatureFD's AMLX Position: Q2 2026 in Review

SignatureFD reduced its Amylyx Pharmaceuticals (AMLX) stake by 63% in Q2 2026, selling an estimated $2.49K and leaving 93 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3168.

SignatureFD first reported a position in AMLX in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.53K in Q1 2026. 17 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • SignatureFD held 93 shares of Amylyx Pharmaceuticals worth $1.67K as of Q2 2026.
  • SignatureFD sold 161 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $2.49K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3168 holding.
  • SignatureFD first reported a position in Amylyx Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • SignatureFD's Amylyx Pharmaceuticals position peaked at $3.53K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.